Speech-Language Pathologists in Smithton, IL Accepting Medicare
6 Speech-Language Pathologists found. Showing 1 - 6
 Amy Y Pfingsten Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 Eugenia, Smithton, IL 62285 Phone: 618-550-8213 Fax: 618-222-1520 |
Mrs. Amy Christine Morra, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 316 S Hickory St, Smithton, IL 62285 Phone: 618-233-6863 |
 Small Talk Speech Therapy, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 Eugenia Dr, Smithton, IL 62285 Phone: 618-550-8213 Fax: 618-222-1520 |
Mrs. Stefanie Banks, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 S Lincoln St, Smithton, IL 62285 Phone: 618-235-4600 |
Progress To Success Speech Therapy Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4940 Wilderness Pt, Smithton, IL 62285 Phone: 618-719-1582 |
Mrs. Amanda Kern, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107 S Lincoln St, Smithton, IL 62285 Phone: 618-235-4600 |
News Archive
Men's health campaign launched to address often overlooked physical, emotional and sexual issues affecting men with diabetes
In addition to dealing with the day-to-day aspects of diabetes management that involve blood glucose, nutrition and lifestyle management, men in the United States with diabetes are also grappling with other physical, emotional and sexual health issues according to survey findings released today by the American Diabetes Association.
Oramed Pharmaceuticals' ORMD-0801 Phase 2a study meets primary and secondary endpoints
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today results from its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes. The trial was conducted under a United States Food and Drug Administration IND (Investigational New Drug) protocol. The Phase 2a study met all primary and secondary endpoints.
NextGen Population Health to be unveiled at 2013 HIMSS Annual Conference and Exhibition
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced the unveiling of its new population health management solution, NextGen Population Health (PH), to help providers meet Patient Centered Medical Home (PCMH) and Accountable Care Organization (ACO) goals, including improving quality, collaborative care, patient engagement and measurement for better health outcomes.
LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5
The London-based LouLou Foundation and the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania have established a Program of Excellence to develop effective treatments for children with CDKL5, a rare X-chromosome-linked genetic disorder that causes severe neuro-developmental impairment and early-onset, difficult-to-control seizures.
› Verified 3 days ago